Bruce Ritchie

7.8k total citations · 1 hit paper
113 papers, 3.2k citations indexed

About

Bruce Ritchie is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Bruce Ritchie has authored 113 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 27 papers in Pulmonary and Respiratory Medicine and 21 papers in Genetics. Recurrent topics in Bruce Ritchie's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers), Hemophilia Treatment and Research (16 papers) and Neuroscience of respiration and sleep (14 papers). Bruce Ritchie is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers), Hemophilia Treatment and Research (16 papers) and Neuroscience of respiration and sleep (14 papers). Bruce Ritchie collaborates with scholars based in Canada, United States and Australia. Bruce Ritchie's co-authors include J. E. Maloney, T. M. Adamson, T. F. Lambert, Daine Alcorn, Peter Robinson, Timothy Craig, T. Yamamuro, Junya Toguchida, Toshikazu Yamaguchi and Guillermo E. Herrera and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Geophysical Research Atmospheres.

In The Last Decade

Bruce Ritchie

107 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung.

1977 378 citations Bruce Ritchie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Ritchie Canada	28	948	758	600	513	513	113	3.2k
Toshiro Nagasawa Japan	35	458 0.5×	581 0.8×	1.5k 2.5×	1.2k 2.3×	397 0.8×	162	4.1k
Nejat Akar Türkiye	32	301 0.3×	479 0.6×	1.3k 2.2×	1.1k 2.1×	462 0.9×	273	3.7k
Daniel Surbek Switzerland	40	649 0.7×	1.1k 1.5×	532 0.9×	917 1.8×	866 1.7×	288	5.4k
David Gillis Australia	37	857 0.9×	316 0.4×	550 0.9×	882 1.7×	410 0.8×	144	4.2k
Joseph A. Lasky United States	39	2.7k 2.9×	342 0.5×	191 0.3×	1.4k 2.7×	449 0.9×	109	4.7k
Enid F. Gilbert United States	39	804 0.8×	313 0.4×	173 0.3×	1.5k 3.0×	1.1k 2.2×	201	5.0k
Filiberto Maria Severi Italy	34	442 0.5×	164 0.2×	286 0.5×	833 1.6×	483 0.9×	219	4.2k
Rina Zaizov Israel	33	668 0.7×	740 1.0×	935 1.6×	931 1.8×	289 0.6×	185	3.5k
Torkell Ellingsen Denmark	30	545 0.6×	258 0.3×	501 0.8×	463 0.9×	790 1.5×	142	3.8k
Giuseppe Francesco Sferrazza Papa Italy	32	803 0.8×	478 0.6×	1.2k 1.9×	397 0.8×	248 0.5×	132	3.5k

Countries citing papers authored by Bruce Ritchie

Since Specialization

Citations

This map shows the geographic impact of Bruce Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Ritchie more than expected).

Fields of papers citing papers by Bruce Ritchie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Ritchie. The network helps show where Bruce Ritchie may publish in the future.

Co-authorship network of co-authors of Bruce Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Ritchie. A scholar is included among the top collaborators of Bruce Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Ritchie. Bruce Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobs, Joshua, William R. Lumry, William H. Yang, et al.. (2025). Safety And Efficacy Of Garadacimab For Hereditary Angioedema Prophylaxis In Patients Aged ≥65 Years. Journal of Allergy and Clinical Immunology. 155(2). AB196–AB196.

Grunebaum, Eyal, Sneha Suresh, Bruce Ritchie, et al.. (2024). 3 Development of the Canadian Inborn Errors of Immunity National Registry (CIEINR). Clinical Immunology. 262. 109945–109945. 1 indexed citations

Craig, Timothy, Donald S. Levy, Avner Reshef, et al.. (2024). Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study. The Lancet Haematology. 11(6). e436–e447. 8 indexed citations

Paterson, D. Ian, James A. White, Christian Beaulieu, et al.. (2024). Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19. Frontiers in Medicine. 11. 1392169–1392169.

Shameli, Afshin, et al.. (2023). Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report. Immunity Inflammation and Disease. 11(10). e1049–e1049. 1 indexed citations

Ritchie, Bruce, et al.. (2022). Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study. Allergy Asthma and Clinical Immunology. 18(1). 99–99. 13 indexed citations

Kobayashi, Roger H., Sudhir Gupta, Isaac Melamed, et al.. (2019). Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies. Frontiers in Immunology. 10. 40–40. 15 indexed citations

Bungard, Tammy J., et al.. (2018). Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals. BMJ Open. 8(10). e022065–e022065. 5 indexed citations

Bungard, Tammy J., et al.. (2017). A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure. Journal of Thrombosis and Thrombolysis. 44(4). 507–515. 5 indexed citations

10.

Schulman, Sam, Bruce Ritchie, Susan Nahirniak, et al.. (2017). Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. Thrombosis Research. 152. 44–48. 44 indexed citations

11.

Craig, Timothy, Konrad Bork, Tom Bowen, et al.. (2012). WAO Guideline for the Management of Hereditary Angioedema. SHILAP Revista de lepidopterología. 5(12). 182–199. 242 indexed citations

12.

Borte, Michael, Isabella Quinti, Annarosa Soresina, et al.. (2011). Efficacy and Safety of Subcutaneous Vivaglobin® Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study. Journal of Clinical Immunology. 31(6). 952–961. 39 indexed citations

13.

Bowen, Tom, et al.. (2010). Management of hereditary angioedema: 2010 Canadian approach. Allergy Asthma and Clinical Immunology. 6(1). 20–20. 9 indexed citations

14.

Ludlam, Christopher A., William G. Powderly, Samuel A. Bozzette, et al.. (2006). Clinical perspectives of emerging pathogens in bleeding disorders. The Lancet. 367(9506). 252–261. 42 indexed citations

15.

Ritchie, Bruce. (2003). Protease inhibitors in the treatment of hereditary angioedema. Transfusion and Apheresis Science. 29(3). 259–267. 27 indexed citations

16.

Sanders, M. Lee, Gregory E. Glass, Robert B. Nadelman, et al.. (1999). Antibody Levels to Recombinant Tick Calreticulin Increase in Humans after Exposure to Ixodes scapularis (Say) and Are Correlated with Tick Engorgement Indices. American Journal of Epidemiology. 149(8). 777–784. 29 indexed citations

17.

Sanders, M. Lee, Deborah C. Jaworski, Jorge L. Sánchez, et al.. (1998). Antibody to a cDNA-derived calreticulin protein from Amblyomma americanum as a biomarker of tick exposure in humans.. American Journal of Tropical Medicine and Hygiene. 59(2). 279–285. 50 indexed citations

18.

Gilchrist, Mark, Anna J. MacDonald, Irina Neverova, Bruce Ritchie, & A. Dean Befus. (1997). Optimization of the isolation and effective use of mRNA from rat mast cells. Journal of Immunological Methods. 201(2). 207–214. 31 indexed citations

19.

Ritchie, Bruce. (1994). Building Management System Integration: The Total Solution. 757. 1 indexed citations

20.

Lee, Charles, Bruce Ritchie, & Cheng‐Chieh Lin. (1994). A tandemly repetitive, centromeric DNA sequence from the Canadian woodland caribou (Rangifer tarandus caribou): Its conservation and evolution in several deer species. Chromosome Research. 2(4). 293–306. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact